Oral Session 2-14A GVHD: Clinic

[OS2-14A-6] GVHD free, relapse free survival in allogeneic transplantation for adult T cell leukemia/lymphoma

Hiroyuki Muranushi¹, Takero Shindo¹, Masakatsu Hishizawa¹, Masahito Tokunaga², Atsushi Wake³, Nobuaki Nakano², Tetsuya Eto⁴, Michihiro Hidaka⁵, Kaname Miyashita⁶, Toshihiro Miyamoto⁷, Takahiro Fukuda⁸, Tatsuo Ichinohe⁹, Yoshiko Atsuta¹⁰, Koji Kato⁷ (1.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 2.Imamura General Hospital, Kagoshima, Japan, 3.Toranomon Hospital, Tokyo, Japan, 4.Hamanomachi Hospital, Fukuoka, Japan, 5.National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan, 6.National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan, 7.Kyushu University Hospital, Fukuoka, Japan, 8.National Cancer Center Hospital, Tokyo, Japan, 9.Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, 10.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)